-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WooBz/uQwXpG4veRW2GWYeoHVbA2w1K9fGT4TqosWC+P32hQ72giVvYGEKILHWMU
 lMogE+OYYYG8hxw92UTwkA==

<SEC-DOCUMENT>0000355019-09-000015.txt : 20091123
<SEC-HEADER>0000355019-09-000015.hdr.sgml : 20091123
<ACCEPTANCE-DATETIME>20091123154429
ACCESSION NUMBER:		0000355019-09-000015
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20090930
ITEM INFORMATION:		Results of Operations and Financial Condition
FILED AS OF DATE:		20091123
DATE AS OF CHANGE:		20091123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		091201665

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>fonar-8k.txt
<TEXT>
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

         Pursuant to Section 13 or 15(d) of the Securities Act of 1934

        Date of Report (Date of earliest event reported): November 23, 2009

                                FONAR CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

    Delaware                    0-10248                       11-2464137
- ---------------             ----------------             -------------------
(State or other             (Commission File              (I.R.S. Employer
jurisdiction of                  Number)                 Identification No.)
incorporation)

                                110 Marcus Drive
                            Melville, New York 11747
                                 (631) 694-2929
              ---------------------------------------------------
               (Address, including zip code, and telephone number
                   of registrant's principal executive office)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ]   Written communications pursuant to Rule 425 under the Securities Act
      (17 CFR 230.425)
[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act
      (17 CFR 240.14a-12)
[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))
[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c)

Item 2.02(a) Results of Operations and Financial Condition.

We reported our results of operations and financial condition for the fiscal
quarter ended September 30, 2009 in a press release dated November 23, 2009.

Exhibits
      99.1 Press Release dated November 23, 2009

                                   SIGNATURES

      Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                FONAR CORPORATION
                                                (Registrant)

                                                By: /s/ Raymond Damadian
                                                    Raymond Damadian
                                                    President and Chairman
Dated:   November 23, 2009
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>x99.txt
<TEXT>
Exhibit 99.1
================================================================================
================================================================================
                                FONAR CORPORATION
                                        *
Fonar MRI news @ aol . com                           Inventor of MR Scanning(TM)
For    Immediate   Release                           An    ISO    9001   Company

Contact:    Daniel  Culver                           110      Marcus       Drive
Director of Communications                           Melville,  New  York  11747
Web site:    www.fonar.com                           Telephone:  (631)  694-2929
Email:  investor@fonar.com                           Fax Number: (631)  390-1709
================================================================================

       FONAR ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2010

MELVILLE,  NEW YORK,  November 23, 2009 - FONAR Corporation  (NASDAQ-FONR),  The
Inventor of MR Scanning(TM), today announced its financial results for the first
quarter of fiscal 2010, which ended September 30, 2009. The loss from operations
improved 23% from a loss of $1.8 million, for the fiscal quarter ended September
30, 2008, to a loss of $1.4 million for the fiscal  quarter ended  September 30,
2009.

The net loss for the first fiscal 2010 quarter ended September 30, 2009 was $1.7
million  including  a  charge  of  $0.4  million  due  to  prepayment  of a note
receivable.  This  compared  to the  fiscal  quarter  one  year  earlier,  ended
September 30, 2008, which was a loss of $0.5 million but included a gain of $1.4
million from the sale of a consolidated subsidiary.

For the first three months of fiscal 2010 ended September 30, 2009, the loss per
common share (basic and diluted) was $0.35, as compared to $0.09 loss per common
share (basic and diluted) for the same period of fiscal 2009.

Total  revenues for the three months ended  September 30, 2009 were $7.5 million
as compared to $6.8  million for the same period one year  earlier.  Service and
repair  revenues  were $2.8  million  in the  first  fiscal  quarter  of 2010 as
compared to $2.6 million in the first quarter of fiscal 2009.  Total  management
and other  fees were at $2.5  million  in the first  fiscal  quarter  of 2010 as
compared to $2.8 million in the first quarter of fiscal 2009.

As of September 30, 2009, there were 140 FONAR UPRIGHT(R) Multi-Position(TM) MRI
units  installed  worldwide.  During  the first  quarter of fiscal  2010,  total
product sales were at $1.6 million.

At the end of the first fiscal quarter of fiscal 2010, total current assets were
$19.2 million,  total assets were $27.5 million,  total current liabilities were
$30.0 million and total long-term liabilities were $2.1 million.  Total cash and
cash equivalents,  and marketable  securities increased 12% from $1.2 million on
June 30, 2009 to $1.4 million on September 30, 2009.

On October 9, 2009,  FONAR announced that the NASDAQ Stock Market notified FONAR
that it complies with all NASDAQ Capital  Market  continued  listing  standards.
Specifically,  the  Company  satisfies  NASDAQ  Listing  Rule  5550(b)(3)  which
requires  the Company to have a minimum  $500,000 of net income from  continuing
operations in the latest fiscal year.

This followed the  announcement  on October 5, 2009 of the Company's most recent
Form 10-K,  whereby net income from  continuing  operations was $1.1 million for
the fiscal year ended June 30,  2009 as compared to a net loss of $13.5  million
for fiscal  2008.  Total  revenues  for the fiscal year ended June 30, 2009 were
$39.7   million  as  compared  to  $35.6   million  for  fiscal   2008.   (Visit
www.fonar.com/news/100509.htm for details.)

"The   Company  is   planning   to  expand   the  number  of  FONAR   UPRIGHT(R)
Multi-Position(TM)  MRI centers under management and to increase the scan volume
at its existing  centers," said Raymond Damadian,  M. D., president and chairman
of FONAR.  "The  UPRIGHT(R)  MRI is a unique scanner with many  advantages  that
other  recumbent-only,  single-position MRI scanners can not perform.  There are
over one million spine surgeries  performed in the United States each year and I
considerate  it  essential  from all we've  learned from our  installed  base of
UPRIGHT(R)  Multi-Position(TM)  scanners  that no  patient  proceed  to  surgery
without  a  prior,  fully  weight-bearing   UPRIGHT(R)   Multi-Position(TM)  MRI
examination.  FBSS, the failed back surgery syndrome,  is a dramatic  diagnostic
category  that should be  retired.  It  currently  is  responsible  for a 0%-40%
failure rate in spine surgery (The Failed Spine,  2005,  p.123, M. Szpalski & R.
Gunzburg,  Lippincott  Williams & Wilkins).  The  literature is now replete with
publications  demonstrating key changes in spine pathology that are visible only
in UPRIGHT(R)  and fully  weight-bearing  MRI and in the full range of positions
the patient normally occupies."

Commenting on the first fiscal  quarter  results,  Dr.  Damadian  said,  "We had
experienced  three straight  quarters of profit before the current quarter which
had a net loss that  included  a loss on a note  receivable.  Given the  medical
advantages of the FONAR  UPRIGHT(R)  Multi-Position(TM)  MRI, and its ability to
provide  landscape  imaging of the entire spine  instead of `snap shots,' we are
confident of the benefits our scanner brings to the public and of our future."

                                       #

            For investor and other information visit: www.fonar.com.

UPRIGHT(R)  and  STAND-UP(R)  are  registered  trademarks and The Inventor of MR
Scanning(TM), Full Range of Motion(TM),  Multi-Position(TM),  True Flow(TM), The
Proof  is  in  the  Picture(TM),  Spondylography(TM)  Spondylometry(TM)  Upright
Radiology(TM),   Landscape(TM),  pMRI(TM),  Dynamic(TM),  and  CSP(TM)  and  are
trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or
may not materialize.  Additional  information on factors that could  potentially
affect the company's  financial  results may be found in the  company's  filings
with the Securities and Exchange Commission.

                                      ###
<PAGE>
                       FONAR CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (000's OMITTED)

ASSETS                                              September 30,    June 30,
                                                        2009           2009
                                                     (UNAUDITED)
Current Assets:                                     -------------  -------------
  Cash and cash equivalents                          $     1,372    $     1,226

  Marketable securities                                       27             23

  Accounts receivable - net                                5,156          5,392

  Accounts receivable - related parties - net                179           -

  Medical receivables - net                                  316            374

  Management fee receivable  net                           3,304          3,274

  Management fee receivable - related
    medical practices - net                                2,020          2,196

  Costs and estimated earnings in excess
    of billings on uncompleted contracts                   1,212          1,476

  Inventories                                              3,452          3,172

  Current portion of advances and notes to related
    medical practices                                        166            165

  Current portion of notes receivable                      1,664            518

  Prepaid expenses and other current assets                  345            472
                                                    -------------  -------------
        Total Current Assets                              19,213         18,288
                                                    -------------  -------------

Property and equipment - net                               2,696          2,892

Advances and notes to related medical practices - net         45             89

Notes receivable  net                                        156          1,779

Other intangible assets - net                              4,951          4,920

Other assets                                                 391            391
                                                    -------------  -------------
        Total Assets                                 $    27,452    $    28,359
                                                    =============  =============
<PAGE>

                       FONAR CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (000's OMITTED)

                                                    September 30,    June 30,
LIABILITIES AND STOCKHOLDERS' DEFICIENCY                 2009          2009
                                                      (UNAUDITED)
Current Liabilities:                                -------------  -------------
  Current portion of long-term debt and
    capital leases                                   $       267    $       277
  Current portion of long-term debt-related party             82             80
  Accounts payable                                         3,816          3,519
  Other current liabilities                                8,429          8,460
  Unearned revenue on service contracts                    5,423          5,526
  Unearned revenue on service
    contracts - related parties                              165           -
  Customer advances                                        9,264          9,238
  Billings in excess of costs and estimated
    earnings on uncompleted contracts                      2,536          2,026
                                                    -------------  -------------
      Total Current Liabilities                           29,982         29,126

Long-Term Liabilities:
  Accounts payable                                           156            184
  Due to related medical practices                           658            643
  Long-term debt and capital leases,
   less current portion                                      731            759
  Long-term debt less current portion-related party          139            160
  Other liabilities                                          379            364
                                                    -------------  -------------
      Total Long-Term Liabilities                          2,063          2,110
                                                    -------------  -------------
      Total Liabilities                                   32,045         31,236
                                                    -------------  -------------
Minority interest                                             64             64
                                                    -------------  -------------

<PAGE>


                       FONAR CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                       (000's OMITTED, except share data)

                                                    September 30,    June 30,
LIABILITIES AND STOCKHOLDERS' DEFICIENCY                2009           2009
     (continued)                                      (UNAUDITED)
                                                    -------------  -------------
STOCKHOLDERS' DEFICIENCY:

Class A non-voting preferred stock $.0001 par
value; 1,600,000 authorized, 313,451 issued and
outstanding at September 30, 2009 and June 30, 2009         -              -

Preferred stock $.001 par value; 2,000,000 shares
authorized, issued and outstanding       none               -              -

Common Stock $.0001 par value; 30,000,000 shares
authorized at September 30, 2009 and June 30, 2009,
4,927,918 and 4,917,918 issued at September 30, 2009
and June 30, 2009, respectively; 4,916,275 and
4,906,275 outstanding at September 30, 2009 and
June 30, 2009, respectively                                    1              1

Class B Common Stock $.0001 par value; 800,000
shares authorized, (10 votes per share), 158
issued and outstanding at September 30, 2009 and
June 30, 2009                                               -               -

Class C Common Stock $.0001 par value; 2,000,000
shares authorized, (25 votes per share), 382,513
issued and outstanding at September 30, 2009 and
June 30, 2009                                               -              -

Paid-in capital in excess of par value                   172,299        172,280
Accumulated other comprehensive loss                         (17)           (21)
Accumulated deficit                                     (176,000)      (174,259)
Notes receivable from employee stockholders                 (265)          (267)
Treasury stock, at cost - 11,643 shares of common
  stock at September 30, 2009 and June 30, 2009             (675)          (675)
                                                    -------------  -------------
    Total Stockholders' Deficiency                        (4,657)        (2,941)
                                                    -------------  -------------
    Total Liabilities and Stockholders' Deficiency   $    27,452    $    28,359
                                                    =============  =============
<PAGE>

                       FONAR CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)
                     (000's OMITTED, except per share data)

                                                     FOR THE THREE MONTHS ENDED
                                                            SEPTEMBER 30,
                                                    ----------------------------
                                                        2009           2008
REVENUES                                            -------------  -------------
  Product sales - net                                $     1,563    $     1,413
  Service and repair fees - net                            2,757          2,545
  Service and repair fees - related parties - net             55             55
  Management and other fees - net                          1,736          2,047
  Management and other fees - related medical
    practices - net                                          795            724
  License fees and royalties                                 585           -
                                                    -------------  -------------
     Total Revenues - Net                                  7,491          6,784
                                                    -------------  -------------
COSTS AND EXPENSES
  Costs related to product sales                           1,657          1,442
  Costs related to service and repair fees                   941          1,010
  Costs related to service and repair fees -
    related parties                                           19             22
  Costs related to management and other fees               1,268          1,203
  Costs related to management and other
    fees - related medical practices                         761            656
  Research and development                                   854            880
  Selling, general and administrative                      3,233          3,265
  Provision for bad debts                                    180            154
                                                    -------------  -------------
     Total Costs and Expenses                              8,913          8,632
                                                    -------------  -------------
Loss From Operations                                      (1,422)        (1,848)

Interest Expense                                             (79)           (79)
Interest Expense - Related Party                              (14)           -
Investment Income                                             87             33
Interest Income - Related Party                                4              6
Other Income                                                  33              1
Minority Interest in Income of Partnerships                 -               (11)
Gain on Sale of Consolidated Subsidiary                     -             1,448
Loss on Note Receivable                                     (350)          -
                                                    -------------  -------------
NET LOSS                                             $    (1,741)   $      (450)
                                                    =============  =============

Basic and Diluted Loss Per Common Share                  $(0.35)       $(0.09)
                                                    =============  =============
Weighted Average Number of Common Shares Outstanding   4,907,942      4,904,275
                                                    =============  =============
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
